Related Experiment Video

Updated: May 9, 2025

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.0K

Effect on Glycemic Control of an Early Intensive Dietary Structured Education Program for Newly Diagnosed Children

Abeer Alassaf1, Lobna Gharaibeh2, Sarah Ibrahim1

  • 1Department of Pediatrics, The University of Jordan, Amman, Jordan.

Pediatric Diabetes
|April 30, 2025
PubMed

Insights

A new dietary program improved glycemic control in children with type 1 diabetes (T1D) compared to conventional education. This intervention was most effective for children over five, showing better blood sugar management in T1D patients.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Diseases

Background:

  • Type 1 diabetes (T1D) management requires effective educational strategies for pediatric patients.
  • Conventional diabetes education may have limitations in achieving optimal glycemic control.
  • The development of innovative educational programs is crucial for improving T1D outcomes.

Purpose of the Study:

  • To compare the effectiveness of a structured educational program (SEP) versus conventional diabetes education on glycemic control in children with T1D.
  • To identify factors influencing the outcomes of the SEP in pediatric T1D patients.

Main Methods:

  • Retrospective medical chart review at Jordan University Hospital.
  • Comparison of glycemic control (HbA1c) between children in the SEP (June 2017-Dec 2019) and conventional education (Jan 2014-Dec 2016).
  • Assessment of various factors, including age, maternal education, and hospital admissions, on SEP outcomes.

Main Results:

  • The SEP group showed significantly lower glycated hemoglobin at 6 and 12 months post-diagnosis compared to the conventional group (P=0.001 and P=0.032, respectively).
  • The SEP demonstrated a better effect on glycemic control in patients older than 5 years.
  • Maternal educational level and prior hospital admissions for DKA/hyperglycemia were predictors of glycemic control at 12 months in the SEP group.

Conclusions:

  • The dietary SEP is associated with superior glycemic control compared to conventional diabetes education at 6 and 12 months post-diagnosis.
  • The positive impact of the SEP is more pronounced in children over 5 years old and those with higher maternal educational attainment.
  • The findings suggest that tailored educational interventions can enhance diabetes management in pediatric populations.
Abstract

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

25.7K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.5K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
204
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
805
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
471
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
121